Assessing the cost-effectiveness of Epstein-Barr virus screening in young men initiating combination therapy with infliximab and azathioprine for Crohn's disease

被引：0
|
作者：
Fennimore, B. [1 ]
Gerich, M. E. [1 ]
Barnes, E. L. [2 ]
Hans, A. K. [3 ]
Herfarth, H. H. [2 ]
Scott, F. I. [1 ,4 ]
机构：
[1] Univ Colorado, Div Gastroenterol & Hepatol, Sch Med, Aurora, CO USA
[2] Univ North Carolina Chapel Hill, Div Gastroenterol & Hepatol, Chapel Hill, NC USA
[3] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA
[4] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P790
引用
收藏
页码：S511 / S511
页数：1
相关论文
共 50 条
  • [1] ASSESSING THE COST-EFFECTIVENESS OF EPSTEIN-BARR VIRUS SCREENING IN YOUNG MEN INITIATING COMBINATION THERAPY WITH INFLIXIMAB AND AZATHIOPRINE FOR CROHN'S DISEASE
    Gerich, Mark E.
    Barnes, Edward L.
    Fennimore, Blair
    Hans, Amneet K.
    Herfarth, Hans H.
    Scott, Frank I.
    GASTROENTEROLOGY, 2018, 154 (06) : S27 - S28
  • [2] Cost-Effectiveness Analysis of Azathioprine vs. Infliximab vs. Combination Therapy for Crohn's Disease
    Reinink, Andrew R.
    Gregory, Martin
    Kymes, Steven
    Dassopoulos, Themistocles
    GASTROENTEROLOGY, 2011, 140 (05) : S175 - S176
  • [3] Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA
    Harris, J. P.
    Saraswathula, A.
    Kaplun, B. D.
    Qian, Y.
    Chan, K. C. A.
    Chan, A. T. C.
    Le, Q. T.
    Owens, D.
    Goldhaber-Fiebert, J. D.
    Pollom, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E401 - E401
  • [4] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
    Gelber, Allan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1086 - 1086
  • [5] Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: A cost-effectiveness analysis
    Saito, Shota
    Shimizu, Utako
    Nan, Zhang
    Mandai, Nozomu
    Yokoyama, Junji
    Terajima, Kenshi
    Akazawa, Kouhei
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (02): : 167 - 174
  • [6] The cost-effectiveness of infliximab in Crohn's disease
    Smart, Claire
    Selinger, Christian P.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (05) : 589 - 598
  • [7] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease REPLY
    Colombel, Jean Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1087 - 1088
  • [8] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
    Colombel, Jean Frederic
    Sandborn, William J.
    Reinisch, Walter
    Mantzaris, Gerassimos J.
    Kornbluth, Asher
    Rachmilewitz, Daniel
    Lichtiger, Simon
    D'Haens, Geert
    Diamond, Robert H.
    Broussard, Delma L.
    Tang, Kezhen L.
    van der Woude, C. Janneke
    Rutgeerts, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1383 - 1395
  • [9] Epstein-Barr Virus-associated Lymphoproliferative Disorder in Crohn Disease Treated With Azathioprine
    Ross, Sherina
    Rajwal, Sanjay Kumar
    Sugarman, Ian
    Picton, Susan
    Devlin, James
    Davison, Suzanne
    McClean, Patricia
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 51 (02): : 229 - 231
  • [10] Epstein-Barr virus viral load in Crohn's disease - Effect of immunosuppressive therapy
    Reijasse, D
    Le Pendeven, C
    Cosnes, J
    Dehee, A
    Gendre, JP
    Nicolas, JC
    Beaugerie, L
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (02) : 85 - 90
12345